CRH Medical (CRH) PT Lowered to C$5.50 at TD Securities

Share on StockTwits

CRH Medical (TSE:CRH) had its target price lowered by TD Securities from C$6.50 to C$5.50 in a research report released on Wednesday morning. The brokerage currently has a buy rating on the stock.

Shares of TSE CRH opened at C$4.13 on Wednesday. The company has a quick ratio of 1.89, a current ratio of 1.99 and a debt-to-equity ratio of 52.51. CRH Medical has a 1 year low of C$3.09 and a 1 year high of C$5.91.

In related news, Director Edward Wright sold 15,000 shares of the firm’s stock in a transaction on Monday, December 10th. The shares were sold at an average price of C$4.89, for a total transaction of C$73,350.00. Also, Director Ian A. Webb sold 29,620 shares of the firm’s stock in a transaction on Wednesday, December 12th. The shares were sold at an average price of C$4.62, for a total transaction of C$136,844.40.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Featured Article: What is Cost of Debt?

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Canaccord Genuity Lowers Peyto Exploration & Development  Price Target to C$12.00
Canaccord Genuity Lowers Peyto Exploration & Development Price Target to C$12.00
InPlay Oil  Price Target Cut to C$2.00
InPlay Oil Price Target Cut to C$2.00
CRH Medical  PT Lowered to C$5.50 at TD Securities
CRH Medical PT Lowered to C$5.50 at TD Securities
Canaccord Genuity Lowers Gibson Energy  Price Target to C$23.00
Canaccord Genuity Lowers Gibson Energy Price Target to C$23.00
Lindsay Co.  Forecasted to Post Q2 2019 Earnings of $0.67 Per Share
Lindsay Co. Forecasted to Post Q2 2019 Earnings of $0.67 Per Share
B. Riley Research Analysts Decrease Earnings Estimates for HomeStreet Inc
B. Riley Research Analysts Decrease Earnings Estimates for HomeStreet Inc


Leave a Reply

© 2006-2019 Ticker Report